Edition:
United Kingdom

People: Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

5.32USD
16 Aug 2019
Change (% chg)

$0.23 (+4.52%)
Prev Close
$5.09
Open
$5.13
Day's High
$5.34
Day's Low
$5.12
Volume
170,944
Avg. Vol
191,036
52-wk High
$21.48
52-wk Low
$4.17

Hagerman, Philip 

Mr. Philip R. Hagerman is Chairman Emeritus of Diplomat Pharmacy, Inc. previously served as Diplomat's Chairman of the Board of Directors and Chief Executive Officer. He has been a director since 1991. Mr. Hagerman co-founded Diplomat with his father in 1975. Mr. Hagerman is also the founder, co-owner and chief executive officer of Skypoint Ventures, an investment entity he founded in 2014. Mr. Hagerman led Diplomat as its principal executive officer and Chairman of the Board of Directors, and his service as a director has continued for approximately 27 years. He has a unique perspective and understanding of our business, culture and history, having led Diplomat through many economic cycles and operational initiatives. His many years of day-to-day leadership of Diplomat gives him critical insights into our operations, strategy and competition. Throughout his career at Diplomat, he demonstrated strong entrepreneurial skills, as well as regulatory, marketing, strategic, and operational expertise. Mr. Hagerman also possesses in-depth knowledge of, and key relationships in, the specialty pharmacy industry on a national basis.

Basic Compensation

Total Annual Compensation, USD 359,098
Restricted Stock Award, USD 99,322
Long-Term Incentive Plans, USD --
All Other, USD 1,216
Fiscal Year Total, USD 459,636

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --